RUDN Journal of MedicineRUDN Journal of MedicineВестник Российского университета дружбы народов. Серия: Медицина2313-02452313-0261Peoples’ Friendship University of Russia named after Patrice Lumumba (RUDN University)3455ArticlesСтатьиReview ArticleDiscussable questions regarding diagnosis of endometrium hyperplasiaДисскутабельные вопросы диагностики гиперплазии эндометрияSlusarevaO AСлюсареваОльга АлександровнаDepartment of Obstetrics and Gynaecology with course of Perinatology Medical FacultyКафедра акушерства и гинекологии с курсом перинатологии Медицинский факультетLelechka.86@mail.ruPeoples’ Friendship University of RussiaРоссийский университет дружбы народов15052013S5NOS5 (2013)№S5 (2013)23023407092016Copyright ©; 2013, Слюсарева О.А.2013Слюсарева О.А.http://creativecommons.org/licenses/by/4.0https://journals.rudn.ru/medicine/article/view/3455Issues regarding diagnosis of endometrium hyperplasia (EH) are still under discussion. Despite of the variety of contradictory scientific investigations performed and an intensive search for EH and endometrium cancer molecular-genetic markers, it is still impossible to choose informative prognostic factors of the formation and development of the disease.Вопросы диагностики гиперплазии эндометрия остаются дисскутабельными до сих пор, несмотря на многообразие противоречивых научных исследований и интенсивный поиск молекулярно-генетических маркеров гиперплазии эндометрия (ГЭ) и рака эндометрия, пока невозможно выбрать информативные прогностические факторы формирования и развития заболевания.endometrial hyperplasiaultrasoundendometrial aspiration biopsyhysteroscopyseparate dilatation and curettageгиперплазия эндометрияУЗИаспирационная биопсия эндометриягистероскопияраздельное лечебно-диагностическое выскабливание1.Akesson E., Gallos I.D., Ganesan R. et al. Prognostic significance of estrogen and progesterone receptor expression in LNG-IUS (Mirena) treatment of endometrial hyperplasia: an immunohistochemical study // Acta Obstet Gynecol Scand. — 2010. — Vol. 89, № 3. — P. 393—398.2.Allison K.H., Tenpenny E., Reed S.D. Immunohistochemical markers in endometrial hyperplasia: is there a panel with promise? A review // Appl Immunohistochem Mol Morphol. — 2008. — Vol. 16, № 4. — P. 329—343.3.American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 426. The role of transvaginal ultrasonography in the evaluation of postmenopausal bleeding // Obstet Gynecol. — 2009. — Vol. 113, № 2 pt. 1. — P. 462—464.4.Armstrong A.J., Hurd W.W., Elguero S. et al. Diagnosis and management of endometrial hyperplasia // J. Minim Invasive Gynecol. — 2012. — Vol. 19, № 5. — P. 562—571.5.Bantysh B.B., Paukov V.S., Cogan E.A. Immunomorfological features of epithelial-stromal relationship with endometrial hyperplasia and cancer / / Archives of Pathology. — 2012. — 74 (3). — P. 22—5.6.Bishtavi A.H., Manukhin I.B., Tabakman J.J. Modern ideas of endometrial hyperplasia and endometrial intraepithelial neoplasia // Problems reproduction. — 2010. — № 6. — P. 52—58.7.Canaani J., Ilan N., Back S. et al. Heparanase expression increases throughout the endometrial hyperplasia-cancer sequence // Int J Gynaecol Obstet. — 2008. — Vol. 101, № 2. — P. 166—171.8.Chakravarty D., Srinivasan R., Ghosh S. et al. Estrogen receptor beta (ERbeta) in endometrial simple hyperplasia and endometrioid carcinoma // Appl Immunohistochem Mol Morphol. — 2008. — Vol. 16, № 6. — P. 535—542.9.Chernuha G.E., Dumanovskaya M.R., Burmenskaya O.V. et al. Expression of genes which regulate apoptosis in different types of endome trial hyperplasia and endometrial carcinoma // Obstetrics and Gynecology. — 2013. — № 1. — P. 63—69.10.Goldstein S.R. Modern evaluation of the endometrium // Obstet Gynecol. — 2010. — Vol. 116, № 1. — P. 168—176.11.Gynecology. Guidance for practical training: a training manual / Ed. V.E. Radzinsky. 3rd ed. — M.: GEOTAR-Media, 2013. — P. 552.12.Jacobs I., Gentry-Maharaj A., Burnell M. et al. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort // Lancet Oncol. — 2011. — Vol. 12, № 1. — P. 38—48.13.Jankowska A.G., Andrusiewicz M., Fischer N. et al. Expression of hCG and GnRHs and their receptors in endometrial carcinoma and hyperplasia // Int J Gynecol Cancer. — 2010. — Vol. 20, № 1. — P. 92—101.14.Landrum L.M., Zuna R.E., Walker J.L. Endometrial Hyperplasia, Estrogen Therapy, and the Prevention of Endometrial Cancer // Clinical Gynecologic Oncology. Eight edition / Di Saia P.J., Creasman W.T. — Elsiver, 2012. — P. 123—129.15.Lysenko O.V., Rozhdestvenskaya T.A. Doplerometriya in the diagnosis of endometrial hyperplastic processes // Proc. Abstracts III All-Russian seminar “The reproductive potential of Russia: Kazan reading. Women’s health — the health of the nation”. — Moscow: Publishing House of Journal Status Praesens, 2013. — P. 63—64.16.McCormick B.A., Wilburn R.D., Thomas M.A. et al. Endometrial thickness predicts endometrial hyperplasia in patients with polycystic ovary syndrome // Fertil Steril. — 2011. — Vol. 95, № 8. — P. 2625—2627.17.Monte N.M., Webster K.A., Neuberg D. et al. Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer. — 2010. — Vol. 70, № 15. — P. 6225—6232.18.Nieminen T.T., Gylling A., Abdel-Rahman W.M. et al. Molecular analysis of endometrial tumorigenesis: importance of complex hyperplasia regardless of atypia // Clin Cancer Res. — 2009. — Vol. 15, № 18. — P. 5772—5783.19.Obeidat B., Mohtaseb A., Matalka I. The diagnosis of endometrial hyperplasia on curettage: how reliable is it? // Arch Gynecol Obstet. — 2009. — Vol. 279, № 4. — P. 489—492.20.Orbo A., Kaino T., Arnes M. et al. Prognostic markers for coexistent carcinoma in high-risk endometrial hyperplasia with negative D-score: significance of morphometry, hormone receptors and apoptosis for outcome prediction // Acta Obstet Gynecol Scand. — 2009. — Vol. 88, № 1. — P. 1234—1242.21.Panova E.A., Totchiev G.F., Maiskov I.Y., Uzdenova A.I., Semyatov S.D. Priority risk factors for endometrial hyperplastic processes // Bulletin of Peoples’ Friendship University of Russia. Series “Medicine. Obstetrics and Gynecology”. — 2010. — № 6. — P. 261—265.22.Polyzos N.P., Mauri D., Tsioras S. et al. Intraperitoneal dissemination of endometrial cancer cells after hysteroscopy: a systematic review and meta-analysis // Int J Gynecol Cancer. — 2010. — Vol. 20, № 2. — P. 261—267.23.Radzinsky V.E., Ordiyants I.M., Orazmurad A.A. Maternity advice bureau. — 3rd ed. — Moscow: GEOTAR-Media, 2009.24.Reproductive health: Manual guide / Ed. V.E. Radzinsky. — Moscow: People’s Friendship University of Russia, 2011.25.Salman M.C., Usubutun A., Dogan N.U. et al. The accuracy of frozen section analysis at hysterectomy in patients with atypical endometrial hyperplasia // Clin Exp Obstet Gynecol. — 2009. — Vol. 36, № 1. — P. 31—34.26.Song J.Y., Kim J.W., Lee J.K. et al. BAG-1 expression in normal endometrium, endometrial hyperplasia and endometrial cancer // Acta Obstet Gynecol Scand. — 2008. — Vol. 87, № 8. — P. 862—867.27.Steinbakk A., Gudlaugsson E., Aasprong O.G. et al. Molecular biomarkers in endometrial hyperplasias predict cancer progression // Am J Obstet Gynecol. — 2011. — Vol. 204, № 4. — P. 357e1—357e12.28.Suh-Bergmann E., Hung Y.Y., Armstrong M.A. Complex atypical hyperplasia: the risk of unrecognized adenocarcinoma and value of preoperative dilation and curettage // Obstet Gynecol. — 2009. — Vol. 114, № 3. — P. 523—529.29.Svirsky R., Smorgick N., Rozowski U. et al. Can we rely on blind endometrial biopsy for detection of focal intrauterine pathology? // Am J Obstet Gynecol. — 2008. — Vol. 199, № 2. — P. 115.e1—115.e3.30.Tabakman Y.Y. Endometrial Cancer: A Guide for doctors. — M.: Practical Medicine, 2009. — P. 12—19.